600129.SHG Chongqing Taiji Industry Group Co Ltd
- Market cap
- CNY 7.23B
- P/E
- -
- P/B
- 2.00x
- ROE
- 1.0%
- Dividend yield
- 1.67%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 600129.SHG undervalued?
Graham numberThe Graham number of Chongqing Taiji Industry Group Co Ltd cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Chongqing Taiji Industry Group Co Ltd fundamental analysis
No fundamental analysis for Chongqing Taiji Industry Group Co Ltd yet.
Chongqing Taiji Industry Group Co Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Chongqing Taiji Industry Group Co Ltd
Chongqing Taiji Industry(Group) Co.,Ltd, together with its subsidiaries, engages in the production and sales of Chinese and western medicine products in China and internationally. It operates through Pharmaceutical Industry; Pharmaceutical Business; Chinese medicinal materials Resources; Big Health and International; and Service Industry and Others segments. The company offers respiratory system, digestive system and metabolic, nervous system, cardiovascular and cerebrovascu…
Full company profileChongqing Taiji Industry Group Co Ltd financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Chongqing Taiji Industry Group Co Ltd annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 7.95B | 8.77B | 10.7B | 11.6B | 11.2B | 12.1B | 14.1B | 15.6B | 12.4B | 10.4B | 9.57B |
| Gross Profit | 2.40B | 3.21B | 4.29B | 4.93B | 4.52B | 5.10B | 6.36B | 7.49B | 4.83B | 2.76B | 2.77B |
| Operating Income | 858M | 183M | 149M | 80.1M | 157M | -497M | 438M | 1.02B | 389M | 336M | 211M |
| EBITDA | -133M | 599M | 668M | 487M | 92.6M | 58.8M | 974M | 1.44B | 758M | 336M | 241M |
| Net Income | 856M | 97.7M | 70.3M | -70.8M | 66.1M | -523M | 354M | 822M | 26.7M | 121M | 34.3M |
| EPS | 2.01 | 0.23 | 0.13 | -0.13 | 0.12 | -0.94 | 0.64 | 1.48 | 0.05 | 0.22 | 0.06 |
| Balance Sheet | |||||||||||
| Total Assets | 9.42B | 10.7B | 12.9B | 14.2B | 14.5B | 13.2B | 14.7B | 14.4B | 14.1B | 14.4B | 14.1B |
| Total Liabilities | 8.14B | 9.45B | 9.61B | 11.0B | 11.3B | 10.6B | 11.8B | 10.7B | 10.4B | 10.6B | 10.4B |
| Shareholders' Equity | 1.28B | 1.23B | 3.29B | 3.17B | 3.24B | 2.73B | 3.06B | 3.62B | 3.49B | 3.50B | 3.53B |
| Cash & Short-term Investments | 1.42B | 1.16B | 1.91B | 2.43B | 2.38B | 1.86B | 2.61B | 2.10B | 953M | 1.17B | 518M |
| Total Debt | 4.04B | 4.94B | 4.70B | 4.64B | 5.20B | 4.75B | 4.55B | 3.73B | 4.82B | 6.05B | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | -106M | -140M | 104M | 327M | 750M | 559M | 1.80B | 672M | -631M | 587M | - |
| Capital Expenditure | 322M | 481M | 691M | 987M | 802M | 500M | 530M | 836M | 832M | 523M | 364M |
| Free Cash Flow | -428M | -622M | -587M | -659M | -51.9M | 58.7M | 1.27B | -164M | -1.46B | 64.1M | -674M |
| Ratios | |||||||||||
| ROE | 66.7% | 8.0% | 2.1% | -2.2% | 2.0% | -19.2% | 11.6% | 22.7% | 0.8% | 3.4% | 1.0% |
| ROA | 9.1% | 0.9% | 0.5% | -0.5% | 0.5% | -4.0% | 2.4% | 5.7% | 0.2% | 0.8% | 0.2% |
| Net Profit Margin | 10.8% | 1.1% | 0.7% | -0.6% | 0.6% | -4.3% | 2.5% | 5.3% | 0.2% | 1.2% | 0.4% |
| Debt to Equity | 3.14x | 4.02x | 1.43x | 1.46x | 1.61x | 1.74x | 1.48x | 1.03x | 1.38x | 1.73x | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Chongqing Taiji Industry Group Co Ltd dividends
- Dividend yield
- 1.67%
- Forward dividend
- -
- Payout ratio
- 100.4%
- Ex-dividend date
- Jun 7, 2024
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 121M | 0.22 | 100.4% |
| 2024 | CNY 296M | 0.53 | 1,110.1% |
| 2023 | CNY 133M | 0.24 | 16.2% |
| 2022 | CNY 153M | 0.27 | 43.2% |
| 2021 | CNY 179M | 0.32 | - |
| 2020 | CNY 257M | 0.46 | 389.1% |
| 2019 | CNY 55.6M | 0.10 | - |
| 2018 | CNY 234M | 0.43 | 332.5% |
| 2017 | CNY 357M | 0.84 | 365.1% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1.3:1 on Jun 4, 2010.
Who owns Chongqing Taiji Industry Group Co Ltd
- Insiders 40.63%
- Institutions 2.85%
- Public & others 56.52%
- Shares outstanding 551M
- Free float 336M
Chongqing Taiji Industry Group Co Ltd company profile
- Company name
- Chongqing Taiji Industry Group Co Ltd
- Ticker
- 600129.SHG
- ISIN
- CNE000000TQ2
- Exchange
- Shanghai Stock Exchange
- Listed since
- Oct 22, 1997
- Sector
- Healthcare
- Industry
- Pharmaceuticals
- Employees
- 10,864
- Fiscal year end
- December
- Address
- No. 18, Hengshan East Road, Chongqing, China, 401123
- Phone
- 86 23 7280 0072
- Website
- taiji.com
About Chongqing Taiji Industry Group Co Ltd
Chongqing Taiji Industry(Group) Co.,Ltd, together with its subsidiaries, engages in the production and sales of Chinese and western medicine products in China and internationally. It operates through Pharmaceutical Industry; Pharmaceutical Business; Chinese medicinal materials Resources; Big Health and International; and Service Industry and Others segments. The company offers respiratory system, digestive system and metabolic, nervous system, cardiovascular and cerebrovascular, big health, anti-infective, anti-tumor, immunomodulatory drugs; and anti-aging products. It also engages in accommodation, loading and unloading, warehousing, catering, retail, agriculture, wholesale, and aquaculture activities; and research and development of medicinal herb planting. Chongqing Taiji Industry(Group) Co.,Ltd was incorporated in 1979 and is headquartered in Chongqing, China.
Chongqing Taiji Industry Group Co Ltd management
7- Mr. Zongbin YuGM & Director · born 1973
- Mr. Hongtao ZhengDeputy General Manager · born 1980
- Ms. Qian JiangDeputy GM & Secretary of the Board of Directors · born 1972
- Mr. Yonghong YuanDeputy General Manager · born 1967
- Mr. Kang ChenDeputy General Manager · born 1975
- Ms. Haiyan CuiDeputy General Manager · born 1976
- Chuan ChenDeputy Head of Financial Management Department